Skip to main content
. Author manuscript; available in PMC: 2016 Jun 1.
Published in final edited form as: Hypertension. 2015 Apr 27;65(6):1349–1355. doi: 10.1161/HYPERTENSIONAHA.115.05344

Figure 2.

Figure 2

EGFR inhibitor attenuated induction of ADAM17 and GRP78 in response to AngII in VSMCs. Rat VSMCs were pretreated with or without Erlotinib (1 µmol/L for 30 min) and stimulated with AngII (100 nmol/L) for 18 hours. The cell lysates were analyzed by immunoblotting as indicated (means ± SEM, n=4 in each group). *p<0.05 compared with basal. †p<0.05 compared with AngII stimulation.